Mia's Feed
Medical News & Research

COVID-19 Surge in California Driven by New 'Stratus' Variant Tied to Omicron

COVID-19 Surge in California Driven by New 'Stratus' Variant Tied to Omicron

Share this article

COVID-19 cases are rising quickly in California, driven by the new 'stratus' omicron subvariant, with health officials warning about ongoing community transmission and delayed vaccine rollout. Learn the latest updates from experts.

2 min read

COVID-19 cases are once again rising rapidly in California, signaling a concerning trend for public health officials. Recent data from wastewater analysis in Los Angeles and Santa Clara counties shows increased concentrations of the virus, alongside a slight uptick in hospitalizations and outpatient cases. Infectious disease experts, such as Dr. Peter Chin-Hong from UC San Francisco, emphasize that the surge is occurring later than last year but remains significant.

The positivity rates for COVID tests in Los Angeles County have increased to 12.6% as of mid-August, up from 7.6% a month earlier, while Orange County reports a rate of 14.4%, rising from 8.1%. Regional health leaders predict an escalation in COVID-19 cases among children, driven by the back-to-school season. Emergency room visits for COVID-like illnesses among seniors are also on the rise.

A predominant factor in this resurgence is the emergence of the 'stratus' subvariant of COVID-19, classified as an omicron subvariant, which accounts for most of the variants detected in wastewater. Dr. Hudson notes that previous infections with other omicron variants may provide some protection, but reinfections remain possible.

Although this summer's COVID-19 activity appears less severe than last year's peaks, the ongoing wave reflects a notable rise in community transmission. Hospitalizations in L.A. County are approximately half of what was recorded during the same period last year.

Complicating the situation is the delay in the federal rollout of the updated COVID-19 vaccine for fall, attributed to policy changes and licensure uncertainties. Health officials in California warn that the availability and timing of new vaccines may be later than usual, potentially impacting vaccination rates.

Given these developments, experts recommend that individuals at higher risk—such as those over 65, immunocompromised persons, pregnant women, and young children—consider getting vaccinated promptly. The vaccines are believed to still offer protection against severe illness, though the decision to vaccinate should be discussed with healthcare providers.

The delay and policy shifts reflect broader debates within the medical community about vaccine safety and effectiveness. Despite these challenges, vaccination remains a critical tool in preventing severe COVID-19 outcomes. Health authorities urge the public to stay informed about updates and to continue practicing preventive measures.

For more information, source: Medical Xpress

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Low-Cost Drug Formulation Enhances Treatment for Parasitic Worms

A groundbreaking, affordable drug formulation improves efficacy against parasitic worms, reducing doses and facilitating global treatment efforts. Developed with nanotechnology, this innovation promises better accessibility for those affected by helminth infections worldwide.

Youth Vaping and Its Link to Future Substance Use and Health Risks

A comprehensive review links youth vaping to a higher risk of smoking, marijuana, and alcohol use, along with several health and mental health concerns, emphasizing the need for stronger protections for young people.

Study Shows Doubling in In-Home Gun Homicides Among Children Since 2010

A new UCLA-led study reveals that in-home firearm homicides of children have more than doubled since 2010, highlighting the urgent need for targeted prevention efforts to protect vulnerable youth.

Using ChatGPT to Determine Eligibility for Clinical Trials

AI technologies like ChatGPT are revolutionizing clinical trial screening by quickly analyzing patient data to identify eligible candidates, reducing delays and improving trial efficiency.